NUTRA PHARMA CORP. (NPHC) Operating income 2016–2025
NUTRA PHARMA CORP. (NPHC) annual operating income history from SEC filings — each fiscal year as reported.
-$1.5MFY2025 · since FY2016: -$2.0M → -$1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.5M | -66.5% |
| FY2024 | -$878,421 | +1.0% |
| FY2023 | -$886,979 | +53.5% |
| FY2022 | -$1.9M | +4.1% |
| FY2021 | -$2.0M | -115.0% |
| FY2020 | -$924,947 | +24.8% |
| FY2019 | -$1.2M | +34.5% |
| FY2018 | -$1.9M | -36.0% |
| FY2017 | -$1.4M | +32.4% |
| FY2016 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice